294 related articles for article (PubMed ID: 38338724)
21. Structural adaption of axons during de- and remyelination in the Cuprizone mouse model.
Pfeiffer F; Frommer-Kaestle G; Fallier-Becker P
Brain Pathol; 2019 Sep; 29(5):675-692. PubMed ID: 31106489
[TBL] [Abstract][Full Text] [Related]
22. Combination Therapy of Mesenchymal Stem Cell Transplantation and Astrocyte Ablation Improve Remyelination in a Cuprizone-Induced Demyelination Mouse Model.
Madadi S; Shiri E; Pasbakhsh P; Tahmasebi F; Kazemzadeh S; Zibara K; Kashani IR
Mol Neurobiol; 2022 Dec; 59(12):7278-7292. PubMed ID: 36175823
[TBL] [Abstract][Full Text] [Related]
23. The comparative effects of bone marrow mesenchymal stem cells and supernatant transplantation on demyelination and inflammation in cuprizone model.
Tahmasebi F; Asl ER; Vahidinia Z; Faghihi F; Barati S
Mol Biol Rep; 2024 May; 51(1):674. PubMed ID: 38787497
[TBL] [Abstract][Full Text] [Related]
24. Automated analysis of gray matter damage in aged mice reveals impaired remyelination in the cuprizone model.
Gingele S; Möllenkamp TM; Henkel F; Schröder LJ; Hümmert MW; Skripuletz T; Stangel M; Gudi V
Brain Pathol; 2024 Mar; 34(2):e13218. PubMed ID: 37927164
[TBL] [Abstract][Full Text] [Related]
25. Multiple functional therapeutic effects of DL-3-n-butylphthalide in the cuprizone model of demyelination.
Wu Y; Dong L; Huang Q; Sun L; Liao Y; Tang Y; Wu Y
Life Sci; 2019 Sep; 232():116501. PubMed ID: 31163175
[TBL] [Abstract][Full Text] [Related]
26. Astrocytes: Lessons Learned from the Cuprizone Model.
Kipp M
Int J Mol Sci; 2023 Nov; 24(22):. PubMed ID: 38003609
[TBL] [Abstract][Full Text] [Related]
27. The mechanistic target of rapamycin as a regulator of metabolic function in oligodendroglia during remyelination.
Mather ML; Jeffries MA; Wood TL
Curr Opin Pharmacol; 2022 Apr; 63():102193. PubMed ID: 35245799
[TBL] [Abstract][Full Text] [Related]
28. Effects of Bone Marrow Mesenchymal Stem Cells on Myelin Repair and Emotional Changes of a Cuprizone-Induced Demyelination Model.
Lei C; Chen H; Chen K
J Integr Neurosci; 2023 Feb; 22(2):40. PubMed ID: 36992584
[TBL] [Abstract][Full Text] [Related]
29. Disrupted CXCR2 Signaling in Oligodendroglia Lineage Cells Enhances Myelin Repair in a Viral Model of Multiple Sclerosis.
Marro BS; Skinner DD; Cheng Y; Grist JJ; Dickey LL; Eckman E; Stone C; Liu L; Ransohoff RM; Lane TE
J Virol; 2019 Sep; 93(18):. PubMed ID: 31243125
[TBL] [Abstract][Full Text] [Related]
30. Mesenchymal Stem Cells Ameliorate Cuprizone-Induced Demyelination by Targeting Oxidative Stress and Mitochondrial Dysfunction.
Shiri E; Pasbakhsh P; Borhani-Haghighi M; Alizadeh Z; Nekoonam S; Mojaverrostami S; Pirhajati Mahabadi V; Mehdi A; Zibara K; Kashani IR
Cell Mol Neurobiol; 2021 Oct; 41(7):1467-1481. PubMed ID: 32594382
[TBL] [Abstract][Full Text] [Related]
31. Calorie restriction promotes remyelination in a Cuprizone-Induced demyelination mouse model of multiple sclerosis.
Mojaverrostami S; Pasbakhsh P; Madadi S; Nekoonam S; Zarini D; Noori L; Shiri E; Salama M; Zibara K; Kashani IR
Metab Brain Dis; 2020 Oct; 35(7):1211-1224. PubMed ID: 32638202
[TBL] [Abstract][Full Text] [Related]
32. Cuprizone-induced demyelination in the rat cerebral cortex and thyroid hormone effects on cortical remyelination.
Silvestroff L; Bartucci S; Pasquini J; Franco P
Exp Neurol; 2012 May; 235(1):357-67. PubMed ID: 22421533
[TBL] [Abstract][Full Text] [Related]
33. Astroglial and oligodendroglial markers in the cuprizone animal model for de- and remyelination.
Castillo-Rodriguez MLA; Gingele S; Schröder LJ; Möllenkamp T; Stangel M; Skripuletz T; Gudi V
Histochem Cell Biol; 2022 Jul; 158(1):15-38. PubMed ID: 35380252
[TBL] [Abstract][Full Text] [Related]
34. Transfer of myelin-reactive th17 cells impairs endogenous remyelination in the central nervous system of cuprizone-fed mice.
Baxi EG; DeBruin J; Tosi DM; Grishkan IV; Smith MD; Kirby LA; Strasburger HJ; Fairchild AN; Calabresi PA; Gocke AR
J Neurosci; 2015 Jun; 35(22):8626-39. PubMed ID: 26041928
[TBL] [Abstract][Full Text] [Related]
35. Dynamics of reactive astrocytes fosters tissue regeneration after cuprizone-induced demyelination.
Schröder LJ; Mulenge F; Pavlou A; Skripuletz T; Stangel M; Gudi V; Kalinke U
Glia; 2023 Nov; 71(11):2573-2590. PubMed ID: 37455566
[TBL] [Abstract][Full Text] [Related]
36. Repurposing of Secukinumab as Neuroprotective in Cuprizone-Induced Multiple Sclerosis Experimental Model via Inhibition of Oxidative, Inflammatory, and Neurodegenerative Signaling.
Abdel-Maged AE; Gad AM; Rashed LA; Azab SS; Mohamed EA; Awad AS
Mol Neurobiol; 2020 Aug; 57(8):3291-3306. PubMed ID: 32514862
[TBL] [Abstract][Full Text] [Related]
37. Influx of T cells into corpus callosum increases axonal injury, but does not change the course of remyelination in toxic demyelination.
Yilmaz EN; Albrecht S; Groll K; Thomas C; Wallhorn L; Herold M; Hucke S; Klotz L; Kuhlmann T
Glia; 2023 Apr; 71(4):991-1001. PubMed ID: 36511515
[TBL] [Abstract][Full Text] [Related]
38. The cuprizone model: regional heterogeneity of pathology.
Wergeland S; Torkildsen Ø; Myhr KM; Mørk SJ; Bø L
APMIS; 2012 Aug; 120(8):648-57. PubMed ID: 22779688
[TBL] [Abstract][Full Text] [Related]
39. Unconventional Myosin ID is Involved in Remyelination After Cuprizone-Induced Demyelination.
Yamazaki R; Baba H; Yamaguchi Y
Neurochem Res; 2018 Jan; 43(1):195-204. PubMed ID: 28986688
[TBL] [Abstract][Full Text] [Related]
40. Targeting demyelination via α-secretases promoting sAPPα release to enhance remyelination in central nervous system.
Llufriu-Dabén G; Carrete A; Chierto E; Mailleux J; Camand E; Simon A; Vanmierlo T; Rose C; Allinquant B; Hendriks JJA; Massaad C; Meffre D; Jafarian-Tehrani M
Neurobiol Dis; 2018 Jan; 109(Pt A):11-24. PubMed ID: 28923597
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
